Cala binding agents, cala peptides and methods of use
WO2016053897A1
Wearable devices configured for facilitating diagnosis and/or assessment of pulmonary diseases, and corresponding methods
WO2016040953A1
Compositions, methods and uses for protecting white blood cells from suppression or death
US2016015346A1
Method for thoracic vertebral bone density measurement by thoracic quantitative computed tomography
US2014329740A1
Anti-infective hydroxy-phenyl-benzoates and methods of use
US2014200219A1
Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases
US2016030533A1
Compositions and methods of treating fungal and bacterial pathogens
WO2014144024A1
Hyr1 compositions and methods for treating fungal and bacterial pathogens
US2014275836A1
Device to monitor and promote successful endotracheal intubation and ventilation
US2014166020A1
Device to secure airway during emergency care
US2014216449A1
Device for surfactant administration and ventilation of low birth weight infants
WO2014093531A1
Modulation of myofiber repair by anti-myostatin in strategies with stem cells
US2014127218A1
Pharmaceutical compositions and methods to vaccinate against candidiasis
US2013344511A1
Use of hematopoietic growth factor inducible neurokinin-1 (hgfin) as a novel biomarker
US2013303563A1
Treatment of peritoneal injury using JAK inhibitors
US2013310307A1
Methods and compositions for treatment of multidrug-resistant bacterial and fungal infections
JP2013139460A
Method and related composition for reducing fat and tightening skin
CN103998057A
Immunotherapy and diagnosis of mucormycosis using CotH
WO2013040478A2
Hyr1-derived compositions and methods of treatment using same
WO2012158529A2
Compositions and methods for immunization against drug resistant acinetobacter baumannii
